lonidamine has been researched along with Cancer of Head in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kleszcz, R; Paluszczak, J | 1 |
| Ciottoli, GB; Magno, L; Terraneo, F | 1 |
| Angelini, F; Ausili Cefaro, GP; Blengio, F; Cirulli, S; Cognetti, F; Colella, E; Giannarelli, D; Lo Russo, V; Merlano, M; Scasso, F | 1 |
| Bardelli, D; Bertoni, F; Ciottoli, GB; Magno, L; Rosignoli, MT; Terraneo, F; Tordiglione, M | 1 |
| DeGregorio, M; Newton, RE; Paggiarino, DA; Scarantino, CW | 1 |
1 review(s) available for lonidamine and Cancer of Head
| Article | Year |
|---|---|
Lonidamine in head and neck cancer: an overview.
Topics: Antineoplastic Agents; Head and Neck Neoplasms; Humans; Indazoles | 1991 |
2 trial(s) available for lonidamine and Cancer of Head
| Article | Year |
|---|---|
Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Indazoles; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1994 |
Double-blind randomized study of lonidamine and radiotherapy in head and neck cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Indazoles; Lymphatic Metastasis; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis; Time Factors | 1994 |
2 other study(ies) available for lonidamine and Cancer of Head
| Article | Year |
|---|---|
The Wnt Signaling Pathway Inhibitors Improve the Therapeutic Activity of Glycolysis Modulators against Tongue Cancer Cells.
Topics: Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Line, Tumor; Cell Survival; Deoxyglucose; Glucose; Glycolysis; Head and Neck Neoplasms; Humans; Indazoles; Pyrimidinones; Tongue; Tongue Neoplasms; Wnt Signaling Pathway | 2022 |
Lonidamine and radiotherapy in head and neck cancers. A pilot study.
Topics: Antineoplastic Agents; Female; Head and Neck Neoplasms; Humans; Indazoles; Male; Pyrazoles; Radiation-Sensitizing Agents | 1984 |